RYDEX SERIES FUNDS's Biotechnology Fund (RYOIX) has disclosed 56 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2022-09-30. The current portfolio value is calculated to be $122.00 Mil, only including common equities, preferred equities, ETFs, options and warrants for equities. The turnover rate is 4%.
Biotechnology Fund (RYOIX)'s Total Assets is $122.80 Mil , Total Liabilities is $262,370.00 , Net Assets is $122.54 Mil.
In Biotechnology Fund (RYOIX)'s current portfolio as of 2022-09-30, the top 5 holdings are , , , and , not including call and put options. Biotechnology Fund (RYOIX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Biotechnology Fund (RYOIX), as well as holding map, valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Biotechnology Fund (RYOIX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Biotechnology Fund.
This section is for PremiumPlus P Membership subscribers only.GuruFocus PremiumPlus P Membership
13F, 13D/G of all institutional investors
Aggregated portfolio of any combinations among them
Manual of Stocks
Excel Add-In unlimited queries
API (20,000 queries/month)
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2022 GuruFocus.com, LLC. All Rights Reserved.